Abnormal red cell features associated with hereditary neurodegenerative disorders: The neuroacanthocytosis syndromes

Current Opinion in Hematology

Volumn 21, Issue 3, 2014, Pages 201-209

  De Franceschi, Lucia ^a   Bosman, Giel J C G M ^b   Mohandas, Narla ^c  

^a UNIVERSITY OF VERONA   (Italy)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NEW YORK BLOOD CENTER   (United States)

Author keywords

chorea acanthocytosis; McLeod syndrome; membrane; phosphorylation; signal transduction

Indexed keywords

ACTIN; PROTEIN KINASE LYN; SPECTRIN; AMINO ACID TRANSPORTER; PANTOTHENATE KINASE; PHOSPHOTRANSFERASE; VESICULAR TRANSPORT PROTEIN; VPS13A PROTEIN, HUMAN; XK PROTEIN, HUMAN;

ACANTHOCYTOSIS; CHOREA-ACANTHOCYTOSIS; CYTOSKELETON; DEGENERATIVE DISEASE; ERYTHROCYTE; GENETIC DISORDER; HUMAN; MCLEOD SYNDROME; NEUROACANTHOCYTOSIS; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; PHYSIOLOGY;

ACANTHOCYTES; AMINO ACID TRANSPORT SYSTEMS, NEUTRAL; CYTOSKELETON; HUMANS; NEUROACANTHOCYTOSIS; PHOSPHOTRANSFERASES (ALCOHOL GROUP ACCEPTOR); VESICULAR TRANSPORT PROTEINS;

EID: 84899481739     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0000000000000035     Document Type: Review

References (87)

1. Estes JW, Morley TJ, Levine IM, Emerson CP. A new hereditary acanthocytosis syndrome. Am J Med 1967; 42:868-881.
2. Levine IM, Estes JW, Looney JM. Hereditary neurological disease with acanthocytosis. A new syndrome. Arch Neurol 1968; 19:403-409.
3. Critchley EM, Clark DB, Wikler A. Acanthocytosis and neurological disorder without betalipoproteinemia. Arch Neurol 1968; 18:134-140.
4. Critchley EM, Clark DB, Wikler A. An adult form of acanthocytosis. Trans Am Neurol Assoc 1967; 92:132-137.
5. Jung HH, Danek A, Walker RH. Neuroacanthocytosis syndromes. Orphanet J Rare Dis 2011; 6:68.
6. Anong WA, Franco T, Chu H, et al. Adducin forms a bridge between the erythrocyte membrane and its cytoskeleton and regulates membrane cohesion. Blood 2009; 114:1904-1912.
7. Perrotta S, Borriello A, Scaloni A, et al. The N-terminal 11 amino acids of human erythrocyte band 3 are critical for aldolase binding and protein phosphorylation: implications for band 3 function. Blood 2005; 106:4359-4366.
8. Mohandas N, Gallagher PG. Red cell membrane: past, present, and future. Blood 2008; 112:3939-3948.
9. Andolfo I, Alper SL, De Franceschi L, et al. Multiple clinical forms of dehydrated hereditary stomatocytosis arise from mutations in PIEZO1. Blood 2013; 121:3925-3935; S3921-S3912.
10. Andolfo I, Alper SL, Delaunay J, et al. Missense mutations in the ABCB6 transporter cause dominant familial pseudohyperkalemia. Am J Hematol 2013; 88:66-72.
11. Iolascon A, De Falco L, Borgese F, et al. A novel erythroid anion exchange variant (Gly796Arg) of hereditary stomatocytosis associated with dyserythropoiesis. Haematologica 2009; 94:1049-1059.
12. Pantaleo A, Ferru E, Giribaldi G, et al. Oxidized and poorly glycosylated band 3 is selectively phosphorylated by Syk kinase to form large membrane clusters in normal and G6PD-deficient red blood cells. Biochem J 2009; 418:359-367.
13. De Franceschi L, Olivieri O, Miraglia delGiudice E, et al. Membrane cation and anion transport activities in erythrocytes of hereditary spherocytosis: effects of different membrane protein defects. Am J Hematol 1997; 55:121-128.
14. De Franceschi L, Bachir D, Galacteros F, et al. Oral magnesium pidolate: effects of long-term administration in patients with sickle cell disease. Br J Haematol 2000; 108:284-289.
15. Holm TM, Braun A, Trigatti BL, et al. Failure of red blood cell maturation in mice with defects in the high-density lipoprotein receptor SR-BI. Blood 2002; 99:1817-1824.
16. Allen DW, Manning N. Cholesterol-loading of membranes of normal erythrocytes inhibits phospholipid repair and arachidonoyl-CoA:1-palmitoyl-sn- glycero-3-phosphocholine acyl transferase. A model of spur cell anemia. Blood 1996; 87:3489-3493.
17. Rampoldi L, Dobson-Stone C, Rubio JP, et al. A conserved sorting-associated protein is mutant in chorea-acanthocytosis. Nat Genet 2001; 28:119-120.
18. Ueno S, Maruki Y, Nakamura M, et al. The gene encoding a newly discovered protein, chorein, is mutated in chorea-acanthocytosis. Nat Genet 2001; 28:121-122.
19. Dobson-Stone C, Velayos-Baeza A, Filippone LA, et al. Chorein detection for the diagnosis of chorea-acanthocytosis. Ann Neurol 2004; 56:299-302.
20. Clark MR, Aminoff MJ, Chiu DT, et al. Red cell deformability and lipid composition in two forms of acanthocytosis: enrichment of acanthocytic populations by density gradient centrifugation. J Lab Clin Med 1989; 113: 469-481.
21. Terada N, Fujii Y, Ueda H, et al. Ultrastructural changes of erythrocyte membrane skeletons in chorea-acanthocytosis and McLeod syndrome revealed by the quick-freezing and deep-etching method. Acta Haematol 1999; 101:25-31.
22. Olivieri O, De Franceschi L, Bordin L, et al. Increased membrane protein phosphorylation and anion transport activity in chorea-acanthocytosis. Haematologica 1997; 82:648-653.
23. De Franceschi L, Tomelleri C, Matte A, et al. Erythrocyte membrane changes of chorea-acanthocytosis are the result of altered Lyn kinase activity. Blood 2011; 118:5652-5663.
24. Melone MA, Di Fede G, Peluso G, et al. Abnormal accumulation of tTGase products in muscle and erythrocytes of chorea-acanthocytosis patients. J Neuropathol Exp Neurol 2002; 61:841-848.
25. Siegl C, Hamminger P, Jank H, et al. Alterations of red cell membrane properties in nneuroacanthocytosis. PLoS ONE 2013; 8:e76715.
26. Jung HH, Danek A, Frey BM. McLeod syndrome: a neurohaematological disorder. Vox Sang 2007; 93:112-121.
27. Ho M, Chelly J, Carter N, et al. Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein. Cell 1994; 77:869-880.
28. Ho MF, Chalmers RM, Davis MB, et al. A novel point mutation in the McLeod syndrome gene in neuroacanthocytosis. Ann Neurol 1996; 39:672-675.
29. Calenda G, Peng J, Redman CM, et al. Identification of two new members, XPLAC and XTES, of the XK family. Gene 2006; 370:6-16.
30. Ballas SK, Bator SM, Aubuchon JP, et al. Abnormal membrane physical properties of red cells in McLeod syndrome. Transfusion 1990; 30:722-727.
31. Redman CM, Huima T, Robbins E, et al. Effect of phosphatidylserine on the shape of McLeod red cell acanthocytes. Blood 1989; 74:1826-1835.
32. De Franceschi L, Scardoni G, Tomelleri C, et al. Computational identification of phospho-tyrosine sub-networks related to acanthocyte generation in neuroacanthocytosis. PLoS ONE 2012; 7:e31015.
33. Walker RH, Liu Q, Ichiba M, et al. Self-mutilation in chorea-acanthocytosis: manifestation of movement disorder or psychopathology? Mov Disord 2006; 21:2268-2269.
34. Bosman GJCGM, de Franceschi L. Neuroacanthocytosis-related changes in erythrocyte membrane organization and function. In: Walker RHSS, Danek A, editors. Neuroacanthocytosis syndromes II. Springer; 2008.
35. Hayflick SJ, Westaway SK, Levinson B, et al. Genetic, clinical, and radiographic delineation of Hallervorden-Spatz syndrome. N Engl J Med 2003; 348:33-40.
36. Hartig MB, Hortnagel K, Garavaglia B, et al. Genotypic and phenotypic spectrum of PANK2 mutations in patients with neurodegeneration with brain iron accumulation. Ann Neurol 2006; 59:248-256.
37. Zhang YM, Rock CO, Jackowski S. Biochemical properties of human pantothenate kinase 2 isoforms and mutations linked to pantothenate kinaseassociated neurodegeneration. J Biol Chem 2006; 281:107-114.
38. Zhou B, Westaway SK, Levinson B, et al. A novel pantothenate kinase gene (PANK2) is defective in Hallervorden-Spatz syndrome. Nat Genet 2001; 28:345-349.
39. Rump P, Lemmink HH, Verschuuren-Bemelmans CC, et al. A novel 3-bp deletion in the PANK2 gene of Dutch patients with pantothenate kinaseassociated neurodegeneration: evidence for a founder effect. Neurogenetics 2005; 6:201-207.
40. Murthy SN, Wilson J, Zhang Y, Lorand L. Residue Gln-30 of human erythrocyte anion transporter is a prime site for reaction with intrinsic transglutaminase. J Biol Chem 1994; 269:22907-22911.
41. Lorand L, Graham RM. Transglutaminases: crosslinking enzymes with pleiotropic functions. Nat Rev Mol Cell Biol 2003; 4:140-156.
42. Cooper AJ, Sheu KR, Burke JR, et al. Transglutaminase-catalyzed inactivation of glyceraldehyde 3-phosphate dehydrogenase and alpha-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length. Proc Natl Acad Sci USA 1997; 94:12604-12609.
43. Foller M, Hermann A, Gu S, et al. Chorein-sensitive polymerization of cortical actin and suicidal cell death in chorea-acanthocytosis. FASEB J 2012; 26:1526-1534.
44. Pantaleo A, De Franceschi L, Ferru E, et al. Current knowledge about the functional roles of phosphorylative changes of membrane proteins in normal and diseased red cells. J Proteomics 2010; 73:445-455.
45. Siciliano A, Turrini F, Bertoldi M, et al. Deoxygenation affects tyrosine phosphoproteome of red cell membrane from patients with sickle cell disease. Blood Cells Mol Dis 2010; 44:233-242.
46. Brunati AM, Bordin L, Clari G, et al. Sequential phosphorylation of protein band 3 by Syk and Lyn tyrosine kinases in intact human erythrocytes: identification of primary and secondary phosphorylation sites. Blood 2000; 96:1550-1557.
47. Slavova-Azmanova NS, Kucera N, Satiaputra J, et al. Gain-of-function Lyn induces anemia: appropriate Lyn activity is essential for normal erythropoiesis and Epo receptor signaling. Blood 2013; 122:262-271.
48. Danek A, Walker RH. Neuroacanthocytosis. Curr Opin Neurol 2005; 18:386-392.
49. Dobson-Stone C, Danek A, Rampoldi L, et al. Mutational spectrum of the CHAC gene in patients with chorea-acanthocytosis. Eur J Hum Genet 2002; 10:773-781.
50. Velayos-Baeza AL, Levecque C, Dobson-Stone C, Monaco AP. The function of chorein. In: Walker RH, Saiki S, Danek A, editors. Neuroacanthocytosis syndromes II. Springer; 2008. pp. 87-105.
51. Velayos-Baeza A, Vettori A, Copley RR, et al. Analysis of the human VPS13 gene family. Genomics 2004; 84:536-549.
52. Velayos-Baeza A, Levecque C, Dobson-Stone C, Monaco AP. The function of chorein. In: Walker RH, Saiki S, Danek A, editors. Neuro-acanthocytosis syndromes II. Springer-Verlag; 2008. pp. 87-105.
53. Stege JT, Laub MT, Loomis WF. Tip genes act in parallel pathways of early Dictyostelium development. Dev Genet 1999; 25:64-77.
54. Abazeed ME, Blanchette JM, Fuller RS. Cell-free transport from the trans-golgi network to late endosome requires factors involved in formation and consumption of clathrin-coated vesicles. J Biol Chem 2005; 280:4442-4450.
55. Abazeed ME, Fuller RS. Yeast Golgi-localized, gamma-Ear-containing, ADP-ribosylation factor-binding proteins are but adaptor protein-1 is not required for cell-free transport of membrane proteins from the trans-Golgi network to the prevacuolar compartment. Mol Biol Cell 2008; 19:4826-4836.
56. Foote C, Nothwehr SF. The clathrin adaptor complex 1 directly binds to a sorting signal in Ste13p to reduce the rate of its trafficking to the late endosome of yeast. J Cell Biol 2006; 173:615-626.
57. Tomemori Y, Ichiba M, Kusumoto A, et al. A gene-targeted mouse model for chorea-acanthocytosis. J Neurochem 2005; 92:759-766.
58. Kurano Y, Nakamura M, Ichiba M, et al. Chorein deficiency leads to upregulation of gephyrin and GABA(A) receptor. Biochem Biophys Res Commun 2006; 351:438-442.
59. Moriguchi S, Nishi M, Komazaki S, et al. Functional uncoupling between Ca2\+ release and afterhyperpolarization in mutant hippocampal neurons lacking junctophilins. Proc Natl Acad Sci USA 2006; 103:10811-10816.
60. Wilburn B, Rudnicki DD, Zhao J, et al. An antisense CAG repeat transcript at JPH3 locus mediates expanded polyglutamine protein toxicity in Huntington's disease-like 2 mice. Neuron 2011; 70:427-440.
61. Kuo YM, Duncan JL, Westaway SK, et al. Deficiency of pantothenate kinase 2 (Pank2) in mice leads to retinal degeneration and azoospermia. Hum Mol Genet 2005; 14:49-57.
62. Brunetti D, Dusi S, Morbin M, et al. Pantothenate kinase-associated neurodegeneration: altered mitochondria membrane potential and defective respiration in Pank2 knock-out mouse model. Hum Mol Genet 2012; 21:5294-5305.
63. Kuo YM, Hayflick SJ, Gitschier J. Deprivation of pantothenic acid elicits a movement disorder and azoospermia in a mouse model of pantothenate kinase-associated neurodegeneration. J Inherit Metab Dis 2007; 30:310-317.
64. Zhang YM, Chohnan S, Virga KG, et al. Chemical knockout of pantothenate kinase reveals the metabolic and genetic program responsible for hepatic coenzyme A homeostasis. Chem Biol 2007; 14:291-302.
65. Wu Z, Li C, Lv S, Zhou B. Pantothenate kinase-associated neurodegeneration: insights from a Drosophila model. Hum Mol Genet 2009; 18:3659-3672.
66. Bosveld F, Rana A, van der Wouden PE, et al. De novo CoA biosynthesis is required to maintain DNA integrity during development of the Drosophila nervous system. Hum Mol Genet 2008; 17:2058-2069.
67. Russo DC, Lee S, Reid ME, Redman CM. Point mutations causing the McLeod phenotype. Transfusion 2002; 42:287-293.
68. Khamlichi S, Bailly P, Blanchard D, et al. Purification and partial characterization of the erythrocyte Kx protein deficient in McLeod patients. Eur J Biochem 1995; 228:931-934.
69. Russo D, Redman C, Lee S. Association of XK and Kell blood group proteins. J Biol Chem 1998; 273:13950-13956.
70. Danek A, Rubio JP, Rampoldi L, et al. McLeod neuroacanthocytosis: genotype and phenotype. Ann Neurol 2001; 50:755-764.
71. Walker RH, Danek A, Uttner I, et al. McLeod phenotype without the McLeod syndrome. Transfusion 2007; 47:299-305.
72. Lee S, Russo D, Redman CM. The Kell blood group system: Kell and XK membrane proteins. Semin Hematol 2000; 37:113-121.
73. Carbonnet F, Hattab C, Collec E, et al. Immunochemical analysis of the Kx protein from human red cells of different Kell phenotypes using antibodies raised against synthetic peptides. Br J Haematol 1997; 96:857-863.
74. Khodadad JK, Weinstein RS, Marsh LW, Steck TL. Shape determinants of McLeod acanthocytes. J Membr Biol 1989; 107:213-218.
75. Kuypers FA, van Linde-Sibenius Trip M, Roelofsen B, et al. The phospholipid organisation in the membranes of McLeod and Leach phenotype erythrocytes. FEBS Lett 1985; 184:20-24.
76. Tang LL, Redman CM, Williams D, Marsh WL. Biochemical studies on McLeod phenotype erythrocytes. Vox Sang 1981; 40:17-26.
77. Manno S, Takakuwa Y, Mohandas N. Modulation of erythrocyte membrane mechanical function by protein 4.1 phosphorylation. J Biol Chem 2005; 280:7581-7587.
78. Salomao M, Zhang X, Yang Y, et al. Protein 4.1R-dependent multiprotein complex: new insights into the structural organization of the red blood cell membrane. Proc Natl Acad Sci USA 2008; 105:8026-8031.
79. Stanfield GM, Horvitz HR. The ced-8 gene controls the timing of programmed cell deaths in C. elegans. Mol Cell 2000; 5:423-433.
80. Walker RH, Morgello S, Davidoff-Feldman B, et al. Autosomal dominant chorea-acanthocytosis with polyglutamine-containing neuronal inclusions. Neurology 2002; 58:1031-1037.
81. Kalfa TA, Pushkaran S, Mohandas N, et al. Rac GTPases regulate the morphology and deformability of the erythrocyte cytoskeleton. Blood 2006; 108:3637-3645.
82. Margolis R. Huntington disease-like 2. In: Pagon RAAM, Bird TD, Dolan CR, et al., editors. Gene reviews (TM). Seattle, WA: University of Washington, Seattle; 2004.
83. Margolis RL, Holmes SE, Rosenblatt A, et al. Huntington's Disease-like 2 (HDL2) in North America and Japan. Ann Neurol 2004; 56:670-674.
84. Trottier Y, Lutz Y, Stevanin G, et al. Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias. Nature 1995; 378:403-406.
85. Johnson MA, Kuo YM, Westaway SK, et al. Mitochondrial localization of human PANK2 and hypotheses of secondary iron accumulation in pantothenate kinase-associated neurodegeneration. Ann N Y Acad Sci 2004; 1012:282-298.
86. Poli M, Derosas M, Luscieti S, et al. Pantothenate kinase-2 (Pank2) silencing causes cell growth reduction, cell-specific ferroportin upregulation and iron deregulation. Neurobiol Dis 2010; 39:204-210.
87. Guehl D, Cuny E, Tison F, et al. Deep brain pallidal stimulation for movement disorders in neuroacanthocytosis. Neurology 2007; 68:160-161.